4.7 Review

The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank

期刊

RHEUMATOLOGY
卷 50, 期 1, 页码 16-24

出版社

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keq155

关键词

NDB; Registry; Data Bank; National Data Bank for rheumatic diseases

资金

  1. Bristol Myers Squibb
  2. UCB
  3. Pfizer

向作者/读者索取更多资源

The National Data Bank (NDB) for rheumatic diseases is a patient-based multi-disease, multi-purpose rheumatic disease registry that has been used primarily to study patients with RA, SLE, FM and OA. It enrols patients from the community, follows up with questionnaires and validates key patient data using medical records. Rheumatologist-written programs make NDB data immediately available to analysts. The NDB has been used to develop and validate diagnostic criteria, develop new questionnaires, describe illness and comorbid disease, assesses disease outcomes and the effect of therapeutic interventions, and measure costs and cost-effectiveness.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据